Original articleA population-based, shared decision-making approach to recruit for a randomized trial of bariatric surgery versus lifestyle for type 2 diabetes
Section snippets
Study setting
Recruitment for this prospective, randomized trial was conducted between July 2011 and June 2012 at Group Health Cooperative (GHC), a large, mixed-model, nonprofit healthcare system that coordinates healthcare and insurance coverage. The GHC system includes>600,000 enrolled members. GHC contracts with the Group Health Physicians medical group to provide care within an integrated group practice (IGP) for approximately 70% of the plan’s enrollees. The remaining 30% receive care from non-GHC
Results
Fig. 1 shows the flow of participant recruitment. We identified 1808 (Box A) members from GHC’s electronic databases who appeared eligible and mailed these individuals an invitation to participate in a telephone survey about their weight and experience with weight loss programs (828 [45.7%] of these had a BMI 30–34.9 kg/m2). Among these, 745 (41%) could not be contacted or, when contacted, refused to participate (Box B). The remaining 1063 (59%) began our telephone survey (Box C). Appendix 1
Discussion
There are many important barriers to conducting randomized trials of bariatric surgery versus nonsurgical treatment. Herein, we tested a pragmatic, SDM recruitment strategy for a randomized trial of RYGB versus an intensive lifestyle intervention for diabetes and obesity in a defined health plan population. Based on our prior study of SDM in bariatric surgery we hypothesized that we would need to contact approximately 100 people to identify one who was willing to be randomly assigned to a
Conclusion
Randomized trials of bariatric surgery are expensive endeavors and challenging to conduct. However, our study provides further evidence that a pragmatic SDM-based recruitment strategy is feasible for randomized trials of bariatric surgery versus intensive lifestyle intervention. Our study also clearly describes the selection biases inherent in recruitment for trials of bariatric surgery, which brings into question the validity of all published trials that fail to report detailed characteristics
Disclosures
David Arterburn receives research funding, has received salary support, and received free access to the DVD decision aids used in this study as a medical editor for the not-for profit (501[3]c) Informed Medical Decisions Foundation (http://www.informedmedicaldecisions.org), which develops content for patient education programs, including the bariatric surgery program that was used the subject of this study. The Foundation has an arrangement with a for-profit company, Health Dialog, to
Acknowledgments
The authors would like to acknowledge the contributions of the following individuals in the conduct of this study: The CROSSROADS Study Team: Chun P. Chan, Allison Devlin, Karen E. Foster-Schubert, Julie Grimm, Mario Kratz, Jessica Kuzma, Skye Stewart, Overlake Hospital Medical Center; Matrix Anesthesia; DSMB members: David McCulloch, Ann Melvin, and Andrew Wright; GHC leadership and staff: Paul Sherman, Michael Evans, and Athina Psomos; Mark Rylander; David Glazer; and the Group Health
References (19)
- et al.
Surgical treatment of obesity and its effect on diabetes: 10-y follow-up
Am J Clin Nutr
(1992) - et al.
Patients enrolled in randomized controlled trials do not represent the inflammatory bowel disease patient population
Clin Gastroenterol Hepatol
(2012) - et al.
Flaws in methods of evidence-based medicine may adversely affect public health directives
Surgery
(2005) - et al.
Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial
JAMA
(2008) - et al.
Bariatric surgery versus intensive medical therapy in obese patients with diabetes
N Engl J Med
(2012) - et al.
Bariatric surgery versus conventional medical therapy for type 2 diabetes
N Engl J Med
(2012) The calibration of treatment effects from clinical trials to target populations
Clin Trials
(2009)- et al.
Making trials matter: pragmatic and explanatory trials and the problem of applicability
Trials
(2009) - et al.
Metabolic/Bariatric Surgery Worldwide 2011
Obes Surg
(2013)
Cited by (0)
This study was funded by the National Institute of Diabetes and Digestive and Kidney Diseases (grant #R01-DK089528) and grants from the Group Health Research Institute and the Group Health Foundation. The video-based decision aid used in this study was provided by the Informed Medical Decisions Foundation.